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 The purpose of this research and systematic literature review is to determine how 
exercise can be incorporated into the treatment of major depressive disorder (MDD) and its 
efficacy. 
Methods 
In this review, four databases were searched including SportDiscus, Pubmed, Cochrane 
Database of Systematic Reviews, and PsycInfo from October 1 to January 5, 2018. A variety of 
key terms were used when searching. Works chosen for review were published after the year 
2000, were peer reviewed, and included randomized control trials (RCTs), pilot studies, 
systematic reviews, and meta-analyses. Sources that were excluded included those published 
prior to the year 2000, had poor study design, and included comorbid psychiatric conditions 
varying from MDD.  
Results  
 For this review, 17 resources were selected. Much of the research presented shows 
evidence for the use of exercise in the treatment of MDD. Although most of the research points to 
exercise as more of a beneficial augmentation strategy for MDD versus a first line therapy involving 
pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) and psychotherapy in disease 
treatment.   
Conclusion 
 Current research on the topic of exercise as therapy for Major Depressive Disorder (MDD) 
does show promise; however, more research still needs to be done in order to place exercise as an 
equivalent treatment to pharmacotherapy or psychotherapy.  
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Introduction 
In the setting of primary care, depression is a disease that is treated and monitored 
multiple times daily by many different providers. In fact, the prevalence of major depressive 
disorder (MDD) in the United States is seven percent, while lifetime prevalence is 16.6 percent, 
and these numbers are only rising (Dynamed Plus, 2017). Unfortunately, failure for proper 
treatment of MDD can have grave consequences for those suffering with depression such as 
suicidality or even becoming a threat to those around them. According to the Diagnostic and 
Statistical Manual of Mental Disorder (DSM-V), the diagnostic criteria for MDD includes five or 
more of the following symptoms that are present for at least two weeks and are a change from 
baseline function, with one of the first two symptoms required to be present for diagnosis: 1) 
depressed mood most of the day or nearly every day or irritability in children and adolescents; 2) 
substantial loss of interest or pleasure in activities most of the day or nearly every day; 3) change 
in weight and appetite without a conscious effort for weight change; 4) increased or decreased 
sleep; 5) psychomotor agitation or retardation; 6) decreased energy and fatigue; 7) excessive 
feelings of worthlessness and inappropriate guilt; 8) decreased concentration or indecisiveness; 
9) thoughts of death, suicidal ideation with or without a plan, or suicide attempt (2013). All the 
listed criteria are by subjective report as well as observable report by others and must cause 
significant decrease in quality of life in multiple areas including social, occupational, and 
personal (DSM-V, 2013). The DSM-V also requires that symptoms may not be due to effects of 
substance or other medical condition (2013).  
Categories of MDD range from mild to severe based on symptoms. MDD is a purely 
clinical diagnosis based on patient history and symptoms. The direct etiology of MDD is not 
certain, but the pathophysiology is hypothesized to be due to an imbalance in the hormones 
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serotonin, tryptophan, noradrenaline, and dopamine. The areas of the brain that show functional 
and structural abnormalities in MDD include anterior cingulate, orbitofrontal cortex, amygdala 
and basal ganglia, hippocampus, prefrontal cortex, ventral striatum, hypothalamic pituitary 
adrenal axis, and the nucleus accumbens (Dynamed Plus, 2017).  
In those with more severe MDD and thoughts of hurting themselves, acute hospitalization 
with 24-hour surveillance and medication management is often necessary. Current 
recommendations for initial treatment of mild to moderate depression includes psychotherapy as 
first line and antidepressants second, while in moderate-to-severe depression it is recommended 
that antidepressants are used in conjunction with psychotherapy as first line treatment (Dynamed 
Plus, 2017). Newer research has been showing the potential benefit of exercise therapy in initial 
treatment of mild to moderate MDD or as augmentation therapy with psychotherapy or 
pharmacotherapy with antidepressants (Dynamed Plus, 2017). Currently, pharmacotherapy is the 
intervention most commonly prescribed for MDD including selective serotonin reuptake 
inhibitors, serotonin and norepinephrine reuptake inhibitors, and other drugs that selectively 
target neurotransmitters. Unfortunately, there is a high number of patients who do not respond to 
pharmacotherapy with about 40 percent, and 70 percent of patients treated with pharmacotherapy 
do not enter remission (Gartlehener et al., 2016).  
From a rural primary care standpoint, pharmacotherapy is the most widely available and 
used treatment for MDD. Psychologists and counselors trained in psychotherapy are more 
difficult to come by than drug stores. In a world where a quick fix is what is wanted, many 
patients would prefer the ease of taking a pill daily over taking time out of their busy life to meet 
with a therapist for treatment. However, a quick fix with antidepressants such as selective 
serotonin reuptake inhibitors (SSRIs) does not come without possibility for adverse effects such 
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as nausea, diarrhea, anorexia, anxiety, headache, insomnia, and sexual dysfunction, not to 
mention the black box warning of increased suicidality during the first couple months of 
treatment in young adults (Dynamed Plus, 2017). Less scarce, but still time consuming, it would 
be worthwhile to assess how exercise therapy can serve as a treatment of those with mild to 
moderate MDD. According to Dynamed Plus (2017), there are multiple potential benefits to 
using exercise are relative affordability, low risk and low likelihood of adverse effects, overall 
wellness benefits, and availability in comparison to pharmacotherapy and psychotherapy.  
An article by Pence, O’Donnell, and Gaynes (2011) stated that of the 12.4 percent of 
patients with MDD in the primary care setting, only 47 percent are recognized and diagnosed by 
their primary care provider. Even more shocking is only 24 percent of those recognized are 
treated and an even lower number of 9 percent are adequately treated. This poses a problem in 
primary care that needs addressing. In many patients with MDD their only contact with medical 
professionals is through their primary care provider. This solidifies the importance of finding 
proper intervention for the wellbeing of such a large primary care patient population.  
The question addressed in this literature review is what role exercise may have in the 
treatment of MDD. Type, duration, and frequency of exercise most efficacious for MDD 
treatment will be assessed as well as comparing exercise to pharmacotherapy, psychotherapy, 
and exercise as augmentation to pharmacotherapy and or psychotherapy. It is expected that 
exercise therapy will have benefits over SSRIs and psychotherapy, but will not necessarily be 
superior to the latter two. A systematic analysis will look at efficacy of the three therapies in 
regard to access to adherence, remission, and improvement of symptoms.  
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Review of Literature 
In this review, four databases were searched including SportDiscus, Pubmed, Cochrane 
Database of Systematic Reviews, and PsycInfo from October 1 to January 5, 2018. A variety of 
key terms were used when searching. In SportDiscus, an Ebscohost database, keywords searched 
were exercise and depression and a filter was added to include only peer reviewed articles after 
the year 2000. A search in PyscInfo yielded works including RCTs as well as systematic 
reviews. Keywords for the PsycInfo database were exercise, cognitive behavioral therapy, major 
depression, major depressive disorder treatment, exercise treatment for major depression, and 
treatment. Again, a filter was added for peer reviewed only and studies were excluded that were 
published before the year 2000. When searching Cochrane Database of Systematic Reviews, the 
keyword depression treatment was used, and a filter was selected for only Cochrane Reviews. 
The final database searched was Pubmed, in which a search was conducted using the MeSH 
headings primary health care, humans, serotonin uptake inhibitors, exercise therapy, and 
exercise. Key terms searched in PsycInfo included MDD, depression, and depressive disorder. 
Sources that were excluded included those published prior to the year 2000, had poor study 
design, and included comorbid psychiatric conditions varying from MDD.  
Pathophysiology of MDD & Mechanism of Exercise as Treatment 
 MDD is a psychiatric condition related to deficits of neurotransmitters as well as 
functional and structural changes in the brain. In twin concordance studies, heritability of MDD 
is about 37 percent, with early-onset and more severe forms of MDD being more heritable 
(Belmaker & Agam, 2008). No one gene, nor has one theory been 100 percent proven in the 
pathogenesis of MDD. One of the most widely accepted theories for MDD is the Monoamine-
Deficiency Hypothesis, which includes the noradrenergic and serotonergic systems. These 
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systems are present in many areas of the brain and involve the neurotransmitters serotonin, 
norepinephrine, tryptophan, noradrenaline, and dopamine. One of the strongest arguments for the 
monoamine theory is the fact nearly every compound or medication that inhibits norepinephrine 
or serotonin reuptake works as an antidepressant and has been clinically proven, such as 
selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors, and 
monoamine oxidase inhibitors (Belmaker & Agam, 2008).  
Another theory endorses structural and functional changes are also associated with MDD 
in the following areas – anterior cingulate, orbitofrontal, amygdala, basal ganglia, hippocampus, 
prefrontal cortex, ventral striatum, hypothalamic pituitary adrenal axis, and nucleus accumbens 
(Dynamed Plus, 2017). Decreased neurogenesis in these areas particularly in the hippocampus is 
a result of MDD (Belmaker & Agam, 2008). Reduction in hippocampal volume and function was 
shown to be decreased in patients with MDD as evidenced by magnetic resonance imaging 
(MRI). Reduction was increased with age and with increasing major depressive episodes. In 
another study, Stockmeier et al. (2004) analyzed tissues from 19 depressed subjects and 21 age 
matched psychiatrically healthy control subjects. For hippocampal thickness, MDD subjects had 
significantly thinner sections than control subjects, p <.002. Pyramidal neurons had a 17-21 
percent decrease in soma size in depressed subjects (Stockmeier et al., 2004). Another study 
done in 2012 evaluated the hippocampus in 17 depressed subjects and 17 non-depressed control 
subjects post-mortem. The volume of the hippocampus was linearly decreased with increasing 
length of depressive illness and increasing depressive episodes, with a p value of <0.026.nYet 
another theory that is widely accepted for the pathogenesis of MDD is the inflammatory and 
oxidative stress hypothesis, which shows that patients with MDD have higher levels of 
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inflammation and increased peripheral blood biomarkers, including cytokines (Dynamed Plus, 
2017).  
 In an article written by Paes, Arias-Carrion, Rocha, Filho, and Machado (2015), 
researchers recognized that the pathogenesis of depression included monoamine deficiency, loss 
of neurotrophic factors such as BDNF, and decreased neurogenesis in the hippocampus. From 
administration of antidepressants, increased BDNF levels were seen. There have also been 
associated systemic effects that contribute to the pathogenesis of depression including immune 
system activation, oxidative stress, and inflammation – specifically interleukin-6 and tumor 
necrosis factor-alpha are increased. Researchers also mentioned how hippocampal neurogenesis 
is suppressed by pro-inflammatory cytokines. As for exercise in the treatment of MDD, it was 
stated that it is likely due to the increased cerebral blood flow and perfusion. Exercise has also 
been shown to increase vascular endothelial growth factor in the brain, leading to increased 
neurogenesis and an antidepressant effect (Paes, Arias-Carrion, Rocha, Filho, & Machado, 
2015).  
The mechanism of action of pharmacotherapy is understood and proven, but how can 
exercise be used to treat MDD? An animal study looked at two groups of rats and measured their 
physical activity by wheel running and level of depression by the forced swim test. Interestingly, 
this study found an increase in cell proliferation in the hippocampus in the running group of rats 
(Bjornebekk, Mathe, & Brene, 2005).  
Introduction to Themes 
 Three themes or categories were identified in the use of exercise for the treatment of 
MDD and include the following – type of exercise for therapeutic benefit, exercise compared to 
pharmacotherapy and psychotherapy, and exercise as adjunctive treatment. The type of exercise 
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evaluated aerobic versus strength training, group exercise versus individual exercise, number of 
sessions of exercise per week, and intensity of exercise needed to provide optimal therapeutic 
benefit for MDD treatment. Most studies that were found comparing exercise to 
pharmacotherapy and psychotherapy used sertraline, an SSRI, and cognitive-behavior therapy 
(CBT) respectively. These studies compared the three methods of treatment mostly by remission 
of MDD, quality of life, and reduction of depressive symptoms. Some studies also looked at 
adherence among the different therapies. Finally, meta-analyses and studies looked at exercise as 
adjunctive therapy for MDD for first line therapy as well as for resistant, refractory MDD. All 
studies included adult participants with a diagnosis of MDD and no other psychiatric 
comorbidities.  
Theme One: Type of Exercise, Intensity, and Dose for Therapeutic Benefit 
In this RCT performed by Doose et al. (2015), researchers were searching for the effect 
physical exercise may have on patients with depression. The trial lasted eight weeks and one 
group of participants performed physical activity throughout, while a control group did not 
perform physical activity. Unique to this study, the group performing exercise got to choose their 
own preferred intensity of exercise. Both groups of participants were kept on their previous 
medical management and all participants had to have a previous diagnosis of mild to severe 
depression. Multiple scales were used to measure fitness and depression, including the Hamilton 
Rating Scale for Depression (HRSD-17) and Beck Depression Inventory. According to 
researchers, results did show a large reduction of depression symptoms as rated by participant 
self-report and scale measurement with the HRSD-17 scores p value of <0.0001 (Doose et al., 
2015). 
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Nystrom, Neely, Hassmen, and Carlbring (2015) completed a systematic overview of 12 
randomized control trials that assessed the treatment of depression in otherwise healthy patients 
with physical activity, which included aerobic activity, anaerobic activity, or both. The goal of 
the overview was to determine what type and dose of physical activity would provide the best 
efficacy for treating depression. Ten studies were selected that had patients diagnosed with major 
depression based on the DSM-IV and the other two studies had participants who were either 
diagnosed with dysthymia or mild depression. The studies included all ages from 12 to 84 and 
both sexes. Most of the studies did not have a control group as they compared two different 
therapies including pharmacotherapy, psychotherapy, and two groups that were offered health 
education. Physical activity was graded measuring frequency, intensity, length of intervention, 
and effect of intervention. Results showed neither aerobic or anaerobic activity were superior, 
and it was concluded that it should be up to the patient preference and ability. The therapeutic 
effect of physical activity is seen at minimum dose three or more times per week for at least 30 
minutes (Nystrom, Neely, Hassmen, & Carlbring, 2015). 
Some limitations to this overview include the lack of control groups, as well as the lack 
of consistency of comparison therapy. The goal of the study was to find what type and “dose” of 
activity practitioners should prescribe, which was not specifically met. With only ten studies 
being reviewed, it is a rather small review. Also, all studies included participants that were not 
already physically active, limiting recommendations to only sedentary individuals suffering from 
depression. Another pitfall, is that not all studies had patients who were diagnosed with major 
depression by the criteria of the DSM-IV. It would have been a better overview had they not 
included the patients with dysthymia and mild depression. More research needs to be done on 
this topic. It is useful to know the “dose” of exercise that is needed to see an effect from a 
EXERCISE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER 13 
 
provider standpoint. Also useful is the fact that neither anaerobic or aerobic exercise were found 
to be superior in the treatment of depression (Nystrom, Neely, Hassmen, & Carlbring, 2015). 
The Cochrane Review performed by Cooney et al. (2013) of 39 studies assessed what 
type of exercise had a stronger clinical evaluation and indicated that mixed aerobic and 
resistance exercise and resistance exercise alone had stronger clinical effects. Mixed (SMD -
.85%, 95% CI -1.85 to .15), resistance (SMD -1.03, 95% CI -1.52 to -.53), and aerobic exercise 
(SMD -0.55, 95% CI -0.77 to -0.34). The review also compared intensity of exercise and clinical 
effect. The largest effect size indicated for vigorous intensity (SMD -0.77, 95% CI -1.3 to -0.24) 
and light/moderate intensity (SMD -0.83, 95% CI -1.32 to -0.34).  This is not very conclusive 
being a large effect is seen with vigorous and light/moderate intensity. Also, duration and 
frequency of exercise was analyzed, which showed large effect sizes were seen for more sessions 
such as 13 to 24 sessions (SMD -0.70, 95% CI -1.09 to -0.31) and 25 to 36 sessions (SMD -0.80, 
95% CI -1.30 to -0.29). While a moderate effect size was seen for 0 to12 sessions (SMD -0.42, 
95% CI -1.26 to 0.43) and 37 or more sessions (SMD -0.70, 95% CI -0.69 to -0.23). These results 
suggest that more sessions have a larger effect, to a certain point, at which then the effect drops 
off (Cooney et al., 2013).  
In the SMILE study completed by Hoffman et al. (2011), a controlled clinical trial was 
done where 202 participants were randomized to four of the following interventions for four 
months; supervised exercise, home-based exercise, sertraline, or placebo pill. Participant 
outcome was measured by the Hamilton Depression Rating Scale score and status of MDD in 
terms of depression, partial remission, or full remission. At four months patient progress was 
assessed which revealed similar benefits between participants treated with exercise and 
sertraline. Twelve months post study, 66 percent of participants had remitted. In follow up, 
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continued self-reported exercise was directly associated to lower depression scores and 
improvement of depressive symptoms. However, the study found that the anti-depressant activity 
of exercise drops after exceeding three hours per week. Results suggest that much similarly to 
antidepressant pharmacotherapy, exercise must continue to be performed in order to see 
antidepressant effects. When participants discontinued exercise, they had worsening of 
symptoms (Hoffman et al., 2011). 
Theme Two: Exercise Compared to SSRIs and Psychotherapy 
Cooney et al. (2013) performed a meta-analysis on 39 studies of adults with depression 
comparing exercise to standard treatment, psychological treatment, or other active treatment. 
Pharmacological and psychological therapy were compared with exercise and found to have no 
significant different in depression treatment. Seven trials with 189 participants compared 
exercise with psychological therapies. Results showed a SMD of -0.03 (95% CI -0.32 to 0.26), 
which indicated that there was not a significant difference between the two groups – an argument 
for the use of exercise. Four trials in this meta-analysis compared exercise with pharmacological 
treatments. Results indicated no significant difference between the two groups with SMD -0.11 
(95% CI -0.34 to 0.12). Results were inconclusive due to the few number of studies done as well 
as the limitations to those studies. However, authors did conclude that based on review, exercise 
is not a more efficacious treatment for depression than antidepressants or psychotherapy, 
however, at the same time, it did not conclude a major difference among the different groups 
treated with exercise versus other therapies. Adverse effects of exercise were reported by a small 
number of trials, but these were not consistent among trials; such effects included chest pain, 
worsening depression, arthralgias, joint swelling, myalgias, and falls (Cooney et al, 2013). 
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In another large review completed by Gartlehenr et al. (2016), 45 studies were assessed in 
regard to primary care treatment of major depression. Therapies included in comparison were 
antidepressants, psychological, complementary and alternative medicine (CAM), and exercise 
treatment in adults with acute MDD. Authors of the review were critical and analytical of the 
current research to date comparing all therapies. Remission rates of MDD were statistically 
similar in those treated with sertraline and aerobic exercise in two trials assessed, however this 
was low quality evidence. CBT and antidepressants had similar response rates (RR, .90 [95% CI, 
.76 to 1.07]) and remission rates (RR, 0.98 [ CI, .73 to 1.32]). However, antidepressants did have 
higher risks for adverse effects (Gartlehenr et al., 2016).  
A final meta-analysis of 13 studies completed by Jonefsson, Lindwall, and Archer 
(2014), studies were collected that compared physical exercise to usual care (which was not 
defined by most of the studies) as well as compared to placebo. As for exercise versus placebo or 
no treatment, exercise showed a large effect in improvement of depressive symptoms (p <0.001) 
in participants with mild to moderate depression. There was not a significant effect found 
between exercise and usual care. Usual care was not defined because many of the studies did not 
include a definition of what usual care meant (Jonefsson, Lindwall, & Archer, 2014).  
From this analysis, it is suggested that exercise is only effective in those with mild to 
moderate depression. In the primary care setting, that is the patient population that is mainly 
being treated as those with more severe depression are often sent to specialists. Using exercise 
therapy in those who are not severely suffering may be an appropriate approach especially 
considering the low risk in comparison with anti-depressant medications. Authors of this analysis 
also pointed out other advantages of exercise compared to usual care such as stress reduction, 
decreased blood pressure, reduced risks for coronary artery diseases, weight reduction, increased 
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oxygenation, and an increase in cognitive functioning as shown in animal studies (Jonefsson, 
Lindwall, & Archer, 2014).  
Theme Three: Exercise as Adjunctive Therapy for Depression 
In this study completed by Greer et al. (2016), a group of participants were selected who 
were considered “partial responders” to antidepressant therapy with SSRIs. They were assigned 
either a high or low dose exercise regimen for 12 weeks and monitored at 6 and 12 weeks by 5 
different scales assessing quality of life along with measurement of depressive symptom severity 
by a clinician and self-report. Completing the study was 101 participants. Results found 
significant improvement in quality of life and functioning in both doses of exercise therapy, and 
an insignificant difference among the two doses. Areas of improvement included physical and 
mental health, social relationships, work, and general life satisfaction (Greer et al., 2016). 
In this study, there are many limitations. First, they did not have a control group. Also, 
they had a rather small group of participants at 101. The population was rather specialized – 
having to be only partially responsive to anti-depressant therapy; although, this is commonly 
seen in the primary care setting. Another limitation is the participants could not have engaged in 
physical activity over the past month, which is leaving out a large group of people who are active 
and do already exercise but still have MDD. Positives to this study is that all participants were on 
the same class of antidepressants and dosing changes were not made throughout the study (Greer 
et al., 2016). 
As mentioned above, depression treatment in the primary care setting is often met with 
some resistance. It is common to see patients who are not completely responsive to 
antidepressant therapy and still have residual depressive symptoms. From a primary care 
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perspective, it is useful to know that adding on exercise to the current medication regimen may 
be sufficient before considering switching medications or increasing dosage (Greer et al., 2016). 
An article in the British Journal of Sports Medicine looked at 12 patients with a known 
diagnosis of major depressive disorder ages 20 to 65. These participants current depressive 
episode lasting an average of 35 weeks and had seen no improvement in the last four weeks of 
being treated with two antidepressants at high doses. Participants were both inpatient and 
outpatient and had a Hamilton Rating Scale for Depression (HAM-D) of 15 or more. Participants 
were not allowed to have an associated comorbidity or schizophrenic symptoms. During the 
study, no changes were made to their current depression regimen other than the augmentation of 
exercise. Exercise included interval training on a treadmill for a duration of 10 days. Patients 
rated their exertion and other parameters were measured such as lactate concentration and heart 
rate. Results showed a great improvement in 5 participants, with their HAMD scores dropping to 
less than 10, while 4 participants showed no improvement (Dimeo, Bauer, Varahram, Proest, & 
Halter, 2001). 
Seiquior et al. performed a RCT with 57 participants with a diagnosis of moderate to 
severe MDD and a HAM-D score of at least 15. All participants were given sertraline 50 
milligrams daily and had no use of antidepressants for the last five weeks. Twenty-nine 
participants were randomized to the exercise intervention, while 28 participants were given 
sertraline alone (Siqueira et al., 2016). 
Results of the study did not show a statistically significant difference between reduction 
in depressive symptoms between the two arms, with a p value of <0.001. However, participants 
in the exercise group had a lower final dose of antidepressants with only 17 percent of the 
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participants in the exercise group taking 100 mg, while 54 percent in the control group 
(medication alone) taking 100 mg of sertraline (Siqueira et al., 2016).  
A study by Murri et al. (2015) included primary care patients 65 to 85 years old whose 
health was compatible with exercise and used the HAM-D. Exercise was scheduled three times 
per week for 60 minutes per session for 24 weeks. Non-progressive exercise worked on strength, 
balance, respiration and motor coordination, and used both mat work and instrumental exercise. 
The progressive exercise used exercise bicycles working on improving cardiopulmonary function 
and increasing intensity. Remission was defined as a HAM-D score of less than 10. Mean 
baseline HAM-D score was 20 (Murri et al., 2015).  
Both non-progressive exercise plus sertraline (SNPE) and progressive exercise with 
sertraline (SPAE) had higher remission rates than sertraline alone, with the following percent 
remission respectively: SPAE 36 percent, SNPE 40 percent, and sertraline 7 percent at 4 weeks, 
(p=0.001). At the end of the study remission rates were the following, SPAE 81 percent, SNPE 
73 percent, and sertraline 45 percent (p=0.001), showing a substantial and statistically significant 
improvement in both groups who participated in exercise. Sertraline 50 milligrams 45 percent 
response, sertraline plus supervised non-progressive exercise 3 times per week 54 percent 
remission, and sertraline plus supervised higher intensity progressive aerobic exercise three times 
per week, 85 percent. P = 0.001. At 24 weeks, sertraline only 45 percent, sertraline plus 
progressive exercise 73 percent, and sertraline plus higher intensity aerobic exercise 81 percent, 
p = 0.001 (Murri et al., 2015).  
Hallgren et al. (2016) looked at 945 adults with mild to moderate depression in the 
primary care setting in Sweden. For 12 weeks, three of the following interventions were assigned 
randomly – supervised group exercise, clinician supported internet-based cognitive-behavioral 
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therapy (ICBT), and usual care for depression. Participants had to have a Patient Health 
Questionnaire (PHQ-9) score greater than nine and participants were included for comorbid 
substance abuse or psychosis (Hallgren et al., 2016). 
  Participants were followed up at 3 months post intervention and again at 12 months. 
Multiple scales were used to measure depression and outcomes including the Montgomery-
Asberg Depression Rating Scale (MADRS), the EuroQol EQ-5D to measure overall health, 
employment, Alcohol Use Disorders Identification Test (AUDIT) for alcohol abuse, and tobacco 
use. Participants who were selected for the exercise intervention completed 3 sessions lasting 60 
minutes for 12 weeks at varying intensities lead by certified personal trainers. The ICBT 
intervention included an explanation by a psychologist of the program followed by working 
through self-help modules. Participants were monitored throughout the 12 weeks by a 
psychologist. Treatment as usual included 45 to 60 minutes of cognitive behavior therapy by a 
psychologist or counsellor and approximately 8 visits to general to their general practitioner. 
Results of the study showed that both ICBT and exercise were as effective as usual care as 
therapy for mild to moderate depression (Hallgren et al., 2016). 
A large pitfall to this study is that usual care was not uniformly controlled and was 
variable in participants. This research is important for the argument of exercise because in the 
rural primary care setting, ICBT and exercise are much more accessible to patients than a trained 
psychologist or counsellor. Also, this implies that exercise therapy is as effective as ICBT or 
usual therapy, but as stated above, usual therapy was not well-defined (Hallgren et al., 2016). 
Discussion 
Type of Exercise, Intensity, and Dose for Therapeutic Benefit 
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In the study completed by Cooney et al. (2013), conclusions were unable to be made on 
what type, frequency, duration, level of supervision, or location of exercise offers patients the 
most benefit. Again, this must be looked at from a patient by patient basis. Authors were quick to 
recognize the inclusiveness of the review, including that studies only included those patients with 
depression who were willing to participate in an exercise program, which many only represent a 
small amount of the MDD population – the true number is not known (Cooney et al., 2013). 
The RCT completed by Doose et al. (2015) allowed participants to choose their own 
intensity of exercise. Although this study cannot help the primary care provider on the exact dose 
of exercise needed to see benefit, it is useful because it showed that leaving the intensity of 
exercise up to the participant may still result in considerable improvement in depressive 
symptoms (Doose et al., 2015).  
The review completed by Nystrom, Neely, Hassmen, and Carlbring (2015) looked at 
which form of exercise was beneficial in the treatment of depression – comparing aerobic 
activity, anaerobic activity, and a combination. Also assessed, was the dose needed for 
therapeutic benefit. It was concluded from this review that no form of activity was superior to 
another when treating depression, which makes it easier as a clinician in terms of prescribing 
exercise. The most effective dose was seen at a minimum of three or more times per week for at 
least 30 minutes. Allowing the patient to pick their desired form of exercise as well as only 
needing to complete the exercise three times per week for 30 minutes make exercise a more 
attractive option in the treatment of MDD (Nystrom, Neely, Hassmen, & Carlbring, 2015). 
A thorough meta-analysis done by Cooney et al. (2013) looked at the level of intensity, 
the type of exercise (aerobic, resistance, and mixed), and the number of sessions that provided 
the most benefit in the treatment of MDD. It was concluded that mixed aerobic and resistance 
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exercise was the most effective, in contrast to the analysis completed by Doose et al. (2015), 
which said that there was no difference. For intensity of exercise, it was not very conclusive 
because both vigorous and light/moderate intensity had large effect sizes. Of note, was that the 
number of sessions that were most effective in MDD treatment were 13 to 36 sessions, while 0 to 
12 and greater than 37 sessions were not as effective. Conclusions that can be drawn by this 
analysis that moderation is more beneficial (Cooney et al., 2013). 
Another study completed by Hoffman et al. showed that the efficacy of exercise drops 
after exceeding three hours per week, which reinforces the findings of Cooney et al. indicating 
that moderation of exercise in MDD treatment is key. This study also concluded that in order to 
see the antidepressant effects of exercise, it must be continued (Hoffman et al., 2011)  
Exercise Compared to SSRIs and Psychotherapy 
In the analysis completed by Cooney et al. (2013) exercise was not shown to be 
statistically different in the efficacy of MDD treatment compared to psychotherapy or 
pharmacotherapy. Conclusions that were drawn from this review are that CBT and 
antidepressant therapy have similar efficacy, and the latter may have more adverse effects. 
Unlike other reviews that showed a benefit to combining psychotherapy and pharmacotherapy, 
this review did not. Recommendations were made that CBT and antidepressant therapy are both 
sufficient first line choices in the treatment of MDD and should be chosen on a patient by patient 
basis. Important take home points from this review are alternate methods to pharmacotherapy 
may show promise in the treatment of mild to moderate MDD. When approaching the patient 
with mild to moderate depression, it is important to acknowledge patient expectations, goals, and 
demographics when deciding on initial treatment (Cooney et al., 2013). 
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 Gartlehenr et al. (2016) performed a large review comparing antidepressants, 
psychological, complementary and alternative medicine (CAM), and exercise treatment in adults 
with MDD. Although there were similar remission rates seen in those treated with sertraline and 
aerobic exercise, this was not high quality evidence. One important note made by this review 
was that antidepressants had more adverse effects than aerobic exercise. This review is important 
for the argument of exercise in the treatment MDD (Gartlehenr et al., 2016). 
Exercise as Adjunctive Therapy for Depression 
The study completed by Siqueira et al. (2016) looking at the antidepressant efficacy of 
aerobic activity using biomarkers is important because with increasing dosing of antidepressants 
comes increasing side effects. Antidepressants such as sertraline are given a warning that they 
take weeks to months to take effect. Starting patients on an exercise regimen at the same time as 
medication administration may result in a quicker improvement of depression symptoms. This 
also helps understand the physiology of exercise and how it may improve depressive symptoms 
by laboratory measures (Siqueira et al., 2016).  
This study by Dimeo, Bauer, Varahram, Proest, and Halter (2001) makes a good point 
that this would be a good initial approach in combination to medical therapy because anti-
depressants typically take two to four weeks to start working, while aerobic activity has a quicker 
onset. A pitfall to this study was that only 12 patients were followed, and 33 percent showed no 
improvement in their depression with therapy. This research is useful for the question of physical 
activity as an adjunctive initial therapy to the heavily prescribed anti-depressants. Starting those 
patients on an exercise regimen while starting medication may further enhance patient well-being 
and improve depression symptoms more quickly (Dimeo, Bauer, Varahram, Proest, & Halter, 
2001). 
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Applicability to Clinical Practice 
 As mentioned earlier, MDD is a disease that is very common in the primary care setting 
and it can have effects on other comorbid conditions and healing, but most importantly on patient 
well-being and quality of life. Current standard for clinical practice are first line treatment with 
either CBT or SSRIs. According to Dynamed Plus, physical activity may be considered as initial 
treatment for people with mild MDD or those who are teetering between a diagnosis of MDD or 
not. However, with this recommendation, Dynamed Plus only has a Level 2 or mid-level 
evidence of recommendation for using exercise in lieu of CBT or MDD. With a lower 
recommendation and lower evidence, it does not mean that studies have conclusively proven 
exercise not as effective as CBT or SSRIs, rather that studies are inconclusive. The research 
presented in this review also reinforces the guidelines from Dynamed Plus, encouraging that 
more research be done to better understand the true potential of exercise for MDD treatment 
(Dynamed Plus, 2017).  
 Based on the studies in this review, however, it can be suggested that exercise may play 
the best role as an augmentation treatment to CBT or SSRIs because it may offer a more rapid 
resolve of symptoms than either of the two alone. SSRIs are especially important because they 
are given a black box warning of increasing suicidality in the first few weeks of treatment.  
 One major component to treating a patient is patient empowerment. Having a health 
condition can leave patients feeling helpless. Giving the patient specific tasks that he or she can 
do to improve his or her health helps give the patient some responsibility and control of his or 
her condition. Offering exercise may be a way to empower the depressed patient and give a task 
or a goal that is easily completed without many side effects or likelihood that it will make the 
patient’s condition worse. Concerns for the use of exercise as a therapy for MDD includes 
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patient compliance as well as access. It is undeniably easier to spend 60 seconds or less per day 
taking a pill in contrast to spending at least 30 minutes every other day exercising. Also, not 
everyone has accessibility to exercise equipment or resides in climates warm enough to 
participate in outdoor physical activity.  
 Although research has been done on this topic and MDD, there is still much that is 
unknown. For example, the true and complete pathogenesis of MDD, much like other psychiatric 
illnesses, is still unknown. And, though improved from the past, there is still an unfortunate 
stigma with mental health. More research needs to be done on both MDD as well as the potential 
for exercise as an effective treatment for the condition. In many of the studies, a large percent of 
the participants were non-compliant with the exercise control. More RCTs need to be completed 
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